AAAAAA
Results:
1-8
|
Results: 8
Authors:
Freeman, BD
Danner, RL
Banks, SM
Natanson, C
Citation: Bd. Freeman et al., Safeguarding patients in clinical trials with high mortality rates, AM J R CRIT, 164(2), 2001, pp. 190-192
Authors:
Quezado, Z
Parent, C
Karzai, W
Depietro, M
Natanson, C
Hammond, W
Danner, RL
Cui, XZ
Fitz, Y
Banks, SM
Gerstenberger, E
Eichacker, PQ
Citation: Z. Quezado et al., Acute G-CSF therapy is not protective during lethal E-coli sepsis, AM J P-REG, 281(4), 2001, pp. R1177-R1185
Authors:
Sevransky, J
Natanson, C
Citation: J. Sevransky et C. Natanson, Anti-inflammatory therapy in sepsis, P C C I D, 2, 2001, pp. 129-143
Authors:
Freeman, BD
Natanson, C
Citation: Bd. Freeman et C. Natanson, Anti-inflammatory therapies in sepsis and septic shock, EXPERT OP I, 9(7), 2000, pp. 1651-1663
Authors:
Zeni, F
Parent, C
Correa, R
Natanson, C
Freeman, B
Fontana, J
Quezado, M
Danner, RL
Ritz, Y
Richmond, S
Gerstenberger, E
Banks, SM
Eichacker, PQ
Citation: F. Zeni et al., ICAM-1 and CD11b inhibition worsen outcome in rats with E-coli pneumonia, J APP PHYSL, 87(1), 1999, pp. 299-307
Authors:
Karzai, W
von Specht, BU
Parent, C
Haberstroh, J
Wollersen, K
Natanson, C
Banks, SM
Eichacker, PQ
Citation: W. Karzai et al., G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects, AM J R CRIT, 159(5), 1999, pp. 1377-1382
Authors:
Quezado, ZMN
Hoffman, WD
Banks, SM
Danner, RL
Eichacker, PQ
Susla, GM
Natanson, C
Citation: Zmn. Quezado et al., Increasing doses of pentoxifylline as a continuous infusion in canine septic shock, J PHARM EXP, 288(1), 1999, pp. 107-113
Authors:
Natanson, C
Esposito, CJ
Banks, SM
Citation: C. Natanson et al., The sirens' songs of confirmatory sepsis trials: Selection bias and sampling error, CRIT CARE M, 26(12), 1998, pp. 1927-1931
Risultati:
1-8
|